Metformin influence on hormone levels at birth, in PCOS mothers and their newborns

Human Reproduction

Volumn 25, Issue 3, 2010, Pages 786-790

  Carlsen, S M ^a,b   Vanky, E ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Metformin; Polycystic ovary syndrome; Pregnancy; Sex hormones; SHBG

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; FOLIC ACID; GLUCURONIDE; METFORMIN; MULTIVITAMIN; PLACEBO; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BIRTH; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; ESTROGEN BLOOD LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MALE; MOTHER; NEWBORN; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; POST HOC ANALYSIS; PREGNANT WOMAN; PROGENY; SEX HORMONE DETERMINATION; TESTOSTERONE BLOOD LEVEL; UMBILICAL ARTERY; VENOUS BLOOD;

EID: 76749163676     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep444     Document Type: Article

References (15)

1. Amato P, Simpson JL. The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:707-718.
2. Barba M, Schunemann HJ, Sperati F, Akl EA, Musicco F, Guyatt G, Muti P. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2009;70:661-670.
3. Dawood MY, Saxena BB. Testosterone and dihydrotestosterone in maternal and cord blood and in amniotic fluid. Am J Obstet Gynecol 1977;129:37-42.
4. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352:1223-1236.
5. Herruzo AJ, Mozas J, Alarcon JL, Lopez JM, Molina R, Molto L, Martos J. Sex differences in serum hormone levels in umbilical vein blood. Int J Gynaecol Obstet 1993;41:37-41.
6. Homburg R. Androgen circle of polycystic ovary syndrome. Hum Reprod 2009;24:1548-1555.
7. Katz E, Ricciarelli E, Adashi EY. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril 1993;59:8-34.
8. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol 2008;199:596-609.
9. Simmons D. Interrelation between umbilical cord serum sex hormones, sex hormone-binding globulin, insulin-like growth factor I, and insulin in neonates from normal pregnancies and pregnancies complicated by diabetes. J Clin Endocrinol Metab 1995;80:2217-2221.
10. Simmons D, France JT, Keelan JA, Song L, Knox BS. Sex differences in umbilical cord serum levels of inhibin, testosterone, oestradiol, dehydroepiandrosterone sulphate, and sex hormone-binding globulin in human term neonates. Biol Neonate 1994;65:287-294.
11. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002;17:2573-2579.
12. van de Beek C, Thijssen JH, Cohen-Kettenis PT, van Goozen SH, Buitelaar JK. Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure? Horm Behav 2004;46:663-669.
13. Vanky E, Salvesen KA, Heimstad R, Fougner KJ, Romundstad P, Carlsen SM. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004; 19:1734-1740.
14. Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil Steril 2005;83:1575-1578.
15. XitaN,TsatsoulisA.Review: fetal programmingofpolycysticovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 2006;91:1660-1666.